CD79-targeted immunotoxins (Genentech)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCD79-targeted immunotoxins (Genentech)

Drug Alias Nameanti-CD79 antibody-drug conjugates (Genentech)anti-CD79b(SN8)-SGD-1269anti-CD79b(SN8)-mcMMAFanti-CD79b(SN8)-mafodotinanti-CD79b(SN8)-MCC-DM1

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionB-cell antigen receptor complex-associated protein beta chain modulators

TargetsB-cell antigen receptor complex-associated protein beta chain

Therapy Area/IndicationsLymphoma, Non-Hodgkin

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGenentech Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGenentech Inc

Active IndicationsN/A

Inactive IndicationsLymphoma, Non-Hodgkin

Other Information

ATC CodeN/A